Archer-Daniels-Midland Company · ADM · FY2026 Q2 · Calendar Q3 2026

ADM Raises 2026 EPS Guidance on Biofuels and Nutrition

The supplied analysis supports a constructive near-term operating narrative: ADM combined strong Q2 adjusted EPS with higher full-year guidance, resilient biofuel margins, and Nutrition growth. The longer-term case depends on sustaining margins and executing capacity, natural-colors, and precision-fermentation initiatives.

Reported Before market openNYSEConsumer Defensive $39.68B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.84 Consensus $1.42
EPS surprise +29.6% Reported versus consensus
Reported revenue $22.68B Consensus $22.75B
Revenue surprise -0.3% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +2.3% Event window
SPY move +1.8% Same window
Abnormal move +0.5% Stock minus SPY
Volume 1.4× Versus trailing sessions
Subsequent drift +5.9% Up to 20 sessions
ADMSPY benchmark

Ask FN2 about ADM FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Q2 results showed adjusted EPS of $1.84 and management raised full-year 2026 adjusted EPS guidance to $5.15-$5.60. The discussion also emphasized stronger Nutrition momentum, four-site crush debottlenecking, and continued investment in precision fermentation and carbon capture.

Guidance delta

Management raised full-year 2026 adjusted EPS guidance to $5.15-$5.60 from the prior quarter's $4.15-$4.70 range.

Key takeaways

  • Q2 adjusted EPS was $1.84, with reported revenue of $22.681 billion.
  • Biofuel margins remained constructive, supported by renewable volume obligations and high energy prices.
  • Nutrition momentum centered on Flavors and Natural Colors.
  • Management is prioritizing debottlenecking, precision fermentation, and decarbonization.
  • Cash generation supports disciplined capex, dividend continuity, and possible opportunistic repurchases.

Management priorities

  • Expand four U.S. crush facilities through debottlenecking.
  • Build precision-fermentation capabilities and microbial-protein products.
  • Scale the natural-colors pipeline with additional customer contracts.
  • Continue carbon-capture and other decarbonization projects.
  • Maintain dividend growth and consider opportunistic share repurchases.

Follow ADM with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
ADM EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q1 '24 estimate $1.36 Q1 '24 actual $1.46, beat Q2 '24 estimate $1.22 Q2 '24 actual $1.03, miss Q3 '24 estimate $1.24 Q3 '24 actual $1.09, miss Q2 '25 estimate $0.82 Q2 '25 actual $0.93, beat Q3 '25 estimate $0.85 Q3 '25 actual $0.92, beat Q4 '25 estimate $0.80 Q4 '25 actual $0.87, beat Q1 '26 estimate $0.64 Q1 '26 actual $0.71, beat Q2 '26 estimate $1.42 Q2 '26 actual $1.84, beat Q3 '26 estimate $1.54 Q4 '26 estimate $1.33 Q1 '27 estimate $1.38
Show 1 more >

Analyst Consensus ?

ConsensusHold36 ratings
Bullish1233.3%
Neutral2261.1%
Bearish25.6%

Analyst 52W Price Targets

$82.34Current
$50Low
$72.94Average
$100High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
UBS Buy BuyMaintainAug 17, 2026
Morgan Stanley Equal Weight UnderweightUpgradeAug 5, 2026
BMO Capital Market Perform Market PerformMaintainAug 5, 2026
Barclays Equal Weight Equal WeightMaintainAug 5, 2026
JP Morgan Underweight UnderweightMaintainMay 6, 2026
Jefferies Hold HoldMaintainApr 6, 2026
B of A Securities Underperform NeutralDowngradeMay 8, 2025
Citigroup Neutral NeutralMaintainApr 15, 2025
Goldman Sachs Neutral NeutralMaintainJan 23, 2024
Stifel Hold BuyDowngradeJan 22, 2024
Roth MKM Neutral BuyDowngradeJan 22, 2024
Baird Neutral OutperformDowngradeJan 22, 2024
Stephens & Co. Equal Weight Equal WeightMaintainOct 25, 2023
Argus Research Buy BuyMaintainAug 1, 2023
Wolfe Research Outperform OutperformMaintainAug 12, 2022
Credit Suisse Neutral NeutralMaintainApr 27, 2022
RBC Capital Outperform OutperformMaintainJan 27, 2021
Seaport Global Buy BuyMaintainJul 28, 2020
Monness, Crespi, Hardt Neutral SellUpgradeMar 2, 2020
Monness Crespi Hardt Neutral SellUpgradeMar 2, 2020
Buckingham Research Buy BuyMaintainJul 19, 2019
Stifel Nicolaus Buy BuyMaintainApr 30, 2019
Argus Buy HoldUpgradeNov 8, 2018
Buckingham Buy BuyMaintainAug 1, 2018
PiperJaffray Neutral NeutralMaintainDec 14, 2016
Macquarie Outperform OutperformMaintainAug 29, 2016
BB&T Capital Hold HoldMaintainJul 12, 2016
Standpoint Research Hold BuyDowngradeApr 28, 2016
Bank of America Neutral BuyDowngradeMar 7, 2016
Vertical Research Hold HoldMaintainJul 7, 2015
Miller Tabak Buy HoldUpgradeJul 7, 2014
Scotiabank Sector Outperform Sector PerformUpgradeFeb 5, 2014
Standpoint Hold BuyDowngradeFeb 13, 2013
Topeka Capital Hold HoldMaintainAug 1, 2012
Topeka Hold HoldMaintainAug 1, 2012
Deutsche Bank Hold HoldMaintainMay 2, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $82.34. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
BarclaysBenjamin Theuer$90$79.87 +9.3%Aug 5, 2026
Morgan StanleySteven K Haynes$79$79.87 -4.1%Aug 5, 2026
Morgan StanleyAnalyst unavailable$60$85.11 -27.1%Jul 20, 2026
UBSManav Gupta$95$80.24 +15.4%Jun 15, 2026
UBSAnalyst unavailable$90$78.02 +9.3%May 7, 2026
Morgan StanleyAnalyst unavailable$58$76.61 -29.6%May 6, 2026
BarclaysAnalyst unavailable$85$79.19 +3.2%May 6, 2026
BarclaysAnalyst unavailable$68$67.52 -17.4%Feb 19, 2026
BMO CapitalAndrew Strelzik$63$67.39 -23.5%Feb 4, 2026
Morgan StanleySteven Haynes$50$60.2 -39.3%Dec 16, 2025
Coker PalmerThomas Palmer$59$60.12 -28.3%Nov 4, 2025
Coker PalmerThomas Palmer$64$62.7 -22.3%Apr 3, 2024
BMO CapitalAndrew Strelzik$60$58.27 -27.1%Mar 13, 2024
Wolfe ResearchSam Margolin$74$58.27 -10.1%Mar 13, 2024
Goldman SachsAdam Samuelson$64$58.27 -22.3%Mar 13, 2024
Stifel NicolausVincent Anderson$58$57.07 -29.6%Mar 12, 2024
CFRAArun Sundaram$67$57.07 -18.6%Mar 12, 2024
BarclaysBenjamin Theurer$60$54.81 -27.1%Mar 11, 2024
Wolfe ResearchSam Margolin$117$84.14 +42.1%Aug 12, 2022
Credit SuisseAnalyst unavailable$92$90 +11.7%Apr 27, 2022
BarclaysBenjamin Theuer$95$92.18 +15.4%Apr 22, 2022
Bank of America SecuritiesSteve Byrne$100$94.46 +21.4%Apr 19, 2022
Stifel NicolausVincent Anderson$100$94.57 +21.4%Apr 11, 2022
StephensBen Bienvenu$67$62.71 -18.6%Oct 12, 2021
Credit SuisseRobert Moskow$60$60.46 -27.1%Apr 27, 2021
Show less

Track every rating change on ADM the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Archer-Daniels-Midland Company (ADM) stands as a major global enterprise in the agricultural sector, focused on the sourcing, transportation, storage, processing, and distribution of a wide array of agricultural commodities, finished goods, and essential ingredients. Its expansive operations span numerous countries, including pivotal markets such as the United States, Switzerland, the Cayman Islands, Brazil, Mexico, and the United Kingdom, alongside a broader international presence. ADM's business is strategically organized into three core divisions: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The company's foundational activities involve acquiring, storing, cleaning, and distributing various agricultural raw materials, including oilseeds, corn, wheat, milo, oats, and barley. Beyond raw material handling, ADM is actively engaged in the global import, export, and distribution of agricultural commodities and feed products, complemented by specialized structured trade finance services.…

Historical context

All ADM earnings

Consumer Defensive peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the ADM recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-04T18:07:49.643482+00:00
  2. FN2 earnings calendar · 2026-09-09T01:23:14.388487+00:00
  3. Polygon adjusted daily market bars · 2026-09-23T03:20:53.111738+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T03:20:53.108989+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.